bf/NASDAQ:PTCT_icon.jpeg

COM:PTCBIO

PTC Therapeutics

  • Stock

Last Close

36.52

25/09 14:39

Market Cap

2.44B

Beta: -

Volume Today

63.37K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
5.38M
-
13.44M
149.87%
17.70M
31.75%
18.99M
7.29%
17.28M
9.03%
18.83M
9.00%
26.19M
39.09%
average payables
872.74K
-
2.63M
200.88%
8.03M
205.95%
9.12M
13.51%
10.79M
18.32%
10.64M
1.38%
8.16M
23.30%
14.49M
77.57%
20.85M
43.84%
25.15M
20.63%
13.63M
45.79%
average receivables
985.77K
-
2.70M
174.04%
7.77M
187.61%
18.01M
131.82%
32.66M
81.34%
54.15M
65.79%
61.72M
13.98%
62.73M
1.64%
90.19M
43.77%
133.03M
47.50%
158.22M
18.93%
book value per share
10.64
-
9.46
11.16%
8.88
6.13%
3.51
60.43%
3.99
13.66%
7.53
88.61%
10.10
34.08%
7.30
27.70%
0.02
99.72%
-4.84
23,811.97%
-0.01
99.77%
capex per share
-0.07
-
-0.15
124.14%
-0.08
45.26%
-0.05
35.51%
-0.08
51.71%
-0.33
321.31%
-0.77
131.51%
-0.85
9.82%
-1.21
42.84%
-2.13
75.52%
-0.00
99.98%
capex to depreciation
-0.35
-
-2.09
491.30%
-0.95
54.68%
-0.54
42.92%
-0.18
67.51%
-0.60
239.45%
-1.41
137.19%
-0.66
53.29%
-1.33
101.73%
-1.18
11.06%
-0.12
89.75%
capex to operating cash flow
0.02
-
0.08
351.80%
0.02
73.14%
0.02
21.61%
0.31
1,697.00%
0.56
82.32%
0.46
18.01%
0.29
37.39%
0.34
17.71%
0.43
25.91%
0.18
58.01%
capex to revenue
-0.03
-
-0.20
652.32%
-0.07
63.58%
-0.02
70.97%
-0.02
25.71%
-0.06
267.74%
-0.15
152.32%
-0.15
0.68%
-0.16
7.77%
-0.22
37.71%
-0.03
86.10%
cash per share
11.10
-
18.40
65.68%
18.43
0.19%
11.90
35.46%
6.91
41.93%
6.13
11.22%
18.43
200.55%
16.71
9.33%
19.26
15.21%
7.55
60.79%
0.01
99.84%
days of inventory on hand
857.59
-
464.30
45.86%
580.06
24.93%
360.28
37.89%
179.02
50.31%
178.16
0.48%
170.43
4.34%
days payables outstanding
-121.72
-
-660.26
442.44%
1.22K
-
172.88
85.81%
310.53
79.62%
359.66
15.82%
260.05
27.69%
222.77
14.34%
days sales outstanding
11.16
-
70.65
533.16%
110.14
55.88%
110.02
0.11%
75.85
31.06%
93.63
23.44%
66.03
29.47%
67.03
1.51%
74.85
11.67%
81.28
8.59%
62.59
22.99%
debt to assets
0.00
-
0.26
-
0.52
100.89%
0.53
1.92%
0.14
74.02%
0.19
41.38%
0.19
1.50%
0.31
60.23%
0.41
35.23%
0.22
46.93%
debt to equity
0.00
-
0.32
-
1.16
266.94%
1.32
13.29%
0.44
66.89%
0.53
21.04%
0.87
65.18%
411.16
47,034.50%
-2.03
100.49%
-0.51
74.99%
dividend yield
earnings yield
-0.24
-
-0.06
75.78%
-0.16
172.69%
-0.38
144.56%
-0.12
68.41%
-0.08
33.71%
-0.09
11.06%
-0.11
22.19%
-0.19
71.67%
-0.20
9.38%
-0.00
99.85%
enterprise value
202.35M
-
1.32B
551.79%
845.17M
35.92%
237.98M
71.84%
607.30M
155.19%
1.52B
150.94%
2.45B
61.06%
4.24B
72.80%
2.46B
41.89%
3.03B
22.97%
2.06T
67,946.87%
enterprise value over ebitda
-4.72
-
-13.27
181.08%
-5.06
61.88%
-1.80
64.36%
-12.42
589.00%
-28.15
126.75%
-21.02
25.35%
-18.62
11.42%
-6.52
64.98%
-8.13
24.78%
-4.69K
57,585.21%
ev to operating cash flow
-4.31
-
-23.03
433.98%
-6.80
70.48%
-2.30
66.20%
-60.35
2,526.38%
-55.13
8.64%
-24.88
54.87%
-21.85
12.17%
-9.81
55.13%
-8.50
13.35%
-13.02K
153,097.16%
ev to sales
6.46
-
57.44
789.17%
22.99
59.98%
2.88
87.48%
3.12
8.57%
5.76
84.26%
8.00
38.90%
11.14
39.31%
4.58
58.92%
4.34
5.22%
2.20K
50,603.88%
free cash flow per share
-3.72
-
-1.96
47.30%
-3.78
92.56%
-3.09
18.11%
-0.34
89.14%
-0.93
175.89%
-2.45
164.07%
-3.79
54.72%
-4.78
26.16%
-7.10
48.56%
-0.00
99.96%
free cash flow yield
-0.22
-
-0.04
82.72%
-0.12
207.68%
-0.28
143.19%
-0.02
92.90%
-0.03
34.09%
-0.05
88.70%
-0.06
21.76%
-0.12
93.31%
-0.19
55.02%
-0.00
99.95%
graham net net
9.96
-
17.40
74.66%
16.61
4.55%
8.05
51.56%
1.82
77.43%
-9.10
601.09%
1.82
119.97%
-8.49
567.54%
-6.94
18.33%
-19.29
178.05%
-0.02
99.88%
graham number
31.03
-
25.14
18.98%
31.82
26.57%
18.16
42.91%
13.46
25.91%
21.59
60.39%
31.16
44.36%
33.01
5.95%
1.85
94.40%
29.13
1,476.58%
0.05
99.84%
income quality
0.91
-
0.61
32.85%
0.73
19.41%
0.73
0.10%
0.13
82.52%
0.22
69.42%
0.39
81.68%
0.44
12.97%
0.48
8.31%
0.64
32.99%
0.25
60.37%
intangibles to total assets
0
-
0
0
0
0.34
Infinity%
0.70
106.12%
0.49
30.24%
0.36
26.02%
0.42
15.30%
0.46
10.96%
0.24
47.28%
interest coverage
-84.25
-
70.61
183.81%
15.96
77.40%
5.32
66.68%
9.21
73.34%
15.43
67.50%
-7.06
145.74%
-4.36
38.27%
-4.84
11.07%
3.40
170.28%
interest debt per share
0.00
-
0.04
886.38%
2.74
7,237.93%
3.84
40.07%
4.95
28.88%
3.02
39.10%
5.12
69.77%
7.22
41.04%
9.61
33.10%
11.08
15.24%
0.00
99.97%
inventory turnover
0.43
-
0.79
84.71%
0.63
19.96%
1.01
61.00%
2.04
101.25%
2.05
0.48%
2.14
4.54%
invested capital
0.00
-
0.32
-
1.16
266.94%
1.32
13.29%
0.44
66.89%
0.53
21.04%
0.87
65.18%
411.16
47,034.50%
-2.03
100.49%
-0.51
74.99%
market cap
217.72M
-
1.63B
650.58%
1.09B
33.33%
371.43M
65.91%
653.57M
75.96%
1.60B
144.58%
2.83B
76.87%
4.03B
42.53%
2.81B
30.35%
2.74B
2.45%
2.06T
75,233.64%
net current asset value
129.66M
-
288.82M
122.74%
286.38M
0.85%
111.52M
61.06%
13.85M
87.58%
-447.64M
3,332.74%
-250.17M
44.11%
-494.55M
97.69%
-1.16B
135.21%
-1.36B
16.82%
-1.50B
10.06%
net debt to ebitda
0.36
-
3.17
784.73%
1.46
53.90%
1.01
30.87%
0.95
6.38%
1.38
45.62%
3.19
131.64%
-0.93
129.11%
0.90
197.36%
-0.79
186.93%
0.41
151.80%
net income per share
-4.02
-
-2.97
26.12%
-5.07
70.66%
-4.17
17.65%
-2.02
51.70%
-2.75
36.39%
-4.27
55.42%
-6.64
55.27%
-7.43
12.04%
-7.79
4.83%
-0.01
99.89%
operating cash flow per share
-3.66
-
-1.81
50.39%
-3.70
103.79%
-3.04
17.73%
-0.26
91.56%
-0.59
131.08%
-1.68
182.37%
-2.94
75.40%
-3.57
21.35%
-4.97
39.41%
-0.00
99.96%
payables turnover
-3.00
-
-0.55
81.56%
0.30
-
2.11
604.94%
1.18
44.33%
1.01
13.66%
1.40
38.30%
1.64
16.74%
receivables turnover
32.71
-
5.17
84.21%
3.31
35.85%
3.32
0.11%
4.81
45.06%
3.90
18.99%
5.53
41.78%
5.45
1.49%
4.88
10.45%
4.49
7.91%
5.83
29.86%
research and ddevelopement to revenue
1.75
-
3.48
98.48%
3.31
4.70%
1.42
57.07%
0.60
57.52%
0.65
7.52%
0.84
29.09%
1.25
49.58%
1.00
19.97%
0.93
7.13%
0.71
23.76%
return on tangible assets
-0.34
-
-0.28
17.13%
-0.46
64.60%
-0.53
13.93%
-0.31
42.11%
-0.38
24.87%
-0.30
20.61%
-0.31
2.60%
-0.46
49.15%
-0.61
31.53%
-0.44
28.28%
revenue per share
2.44
-
0.73
70.21%
1.09
50.30%
2.43
122.19%
4.96
104.22%
5.68
14.57%
5.22
8.25%
5.77
10.58%
7.64
32.54%
9.74
27.46%
0.01
99.87%
roe
-0.38
-
-0.31
16.84%
-0.57
81.80%
-1.19
108.10%
-0.50
57.51%
-0.37
27.69%
-0.42
15.91%
-0.91
114.76%
-364.33
39,976.38%
1.61
100.44%
0.77
52.47%
roic
-0.37
-
-0.32
14.82%
-0.43
34.43%
-0.51
20.21%
-0.18
64.81%
-0.23
27.29%
-0.22
3.05%
-0.43
91.74%
-0.54
27.46%
-0.86
57.54%
1.77
306.82%
sales general and administrative to revenue
0.81
-
1.95
142.45%
2.23
14.38%
1.17
47.39%
0.62
46.88%
0.58
7.03%
shareholders equity per share
10.64
-
9.46
11.16%
8.88
6.13%
3.51
60.43%
3.99
13.66%
7.53
88.61%
10.10
34.08%
7.30
27.70%
0.02
99.72%
-4.84
23,811.97%
-0.01
99.77%
stock based compensation to revenue
0.27
-
0.84
212.59%
0.92
9.90%
0.42
54.20%
0.16
62.86%
0.13
20.10%
0.14
9.27%
0.18
34.56%
0.19
4.06%
0.16
17.85%
0.11
31.36%
tangible asset value
136.54M
-
298.47M
118.59%
298.47M
0%
119.58M
59.93%
23.44M
80.40%
-432.64M
1,945.44%
-198.51M
54.12%
-315.69M
59.03%
-805.74M
155.24%
-1.14B
40.90%
-1.28B
12.78%
tangible book value per share
10.64
-
9.46
11.16%
8.88
6.13%
3.51
60.43%
0.60
82.97%
-9.29
1,652.51%
-3.37
63.69%
-4.78
41.77%
-11.43
139.16%
-15.83
38.42%
-0.02
99.89%
working capital
131.89M
-
291.10M
120.71%
310.56M
6.69%
211.66M
31.85%
167.01M
21.09%
154.06M
7.76%
543.43M
252.73%
954.41M
75.63%
264.03M
72.34%
287.55M
8.91%
615.53M
114.06%

All numbers in (except ratios and percentages)